Affiliation
Cappagh National Orthopaedic Hospital, Finglas, Dublin, Ireland.Issue Date
2013-08Keywords
SURGERYLocal subject classification
SURGERY, ORTHOPAEDICHIP REPLACEMENT
MeSH
Arthroplasty, Replacement, HipCytokines
Hip Prosthesis
Humans
Inflammation Mediators
Osteoblasts
Osteolysis
Prosthesis Failure
Metadata
Show full item recordCitation
O'Neill SC et al. The role of osteoblasts in peri-prosthetic osteolysis. 2013, 95-B (8):1022-6 Bone Joint JPublisher
The bone & joint journalJournal
The bone & joint journalDOI
10.1302/0301-620X.95B8.31229PubMed ID
23908414Abstract
Peri-prosthetic osteolysis and subsequent aseptic loosening is the most common reason for revising total hip replacements. Wear particles originating from the prosthetic components interact with multiple cell types in the peri-prosthetic region resulting in an inflammatory process that ultimately leads to peri-prosthetic bone loss. These cells include macrophages, osteoclasts, osteoblasts and fibroblasts. The majority of research in peri-prosthetic osteolysis has concentrated on the role played by osteoclasts and macrophages. The purpose of this review is to assess the role of the osteoblast in peri-prosthetic osteolysis. In peri-prosthetic osteolysis, wear particles may affect osteoblasts and contribute to the osteolytic process by two mechanisms. First, particles and metallic ions have been shown to inhibit the osteoblast in terms of its ability to secrete mineralised bone matrix, by reducing calcium deposition, alkaline phosphatase activity and its ability to proliferate. Secondly, particles and metallic ions have been shown to stimulate osteoblasts to produce pro inflammatory mediators in vitro. In vivo, these mediators have the potential to attract pro-inflammatory cells to the peri-prosthetic area and stimulate osteoclasts to absorb bone. Further research is needed to fully define the role of the osteoblast in peri-prosthetic osteolysis and to explore its potential role as a therapeutic target in this condition.Item Type
ArticleLanguage
enISSN
2049-4408ae974a485f413a2113503eed53cd6c53
10.1302/0301-620X.95B8.31229
Scopus Count
Collections
Related articles
- Wear and osteolysis in total joint replacements.
- Authors: Kadoya Y, Kobayashi A, Ohashi H
- Issue date: 1998 Feb
- Blockade of XCL1/Lymphotactin Ameliorates Severity of Periprosthetic Osteolysis Triggered by Polyethylene-Particles.
- Authors: Tian Y, Terkawi MA, Onodera T, Alhasan H, Matsumae G, Takahashi D, Hamasaki M, Ebata T, Aly MK, Kida H, Shimizu T, Uetsuki K, Kadoya K, Iwasaki N
- Issue date: 2020
- Semaphorin-3a, neuropilin-1 and plexin-A1 in prosthetic-particle induced bone loss.
- Authors: Saad S, Dharmapatni AASSK, Crotti TN, Cantley MD, Algate K, Findlay DM, Atkins GJ, Haynes DR
- Issue date: 2016 Jan
- Involvement of extracellular Hsp72 in wear particle-mediated osteolysis.
- Authors: Vallés G, García-Cimbrelo E, Vilaboa N
- Issue date: 2012 Mar
- Current concepts in osteolysis.
- Authors: Ollivere B, Wimhurst JA, Clark IM, Donell ST
- Issue date: 2012 Jan